Trial NCT02716805

View at ClinicalTrials.gov 
Org. Study IDs: LUD2014-010

Last trial update was posted on 2022-10-12

MeSH Interventions

Durvalumab Melphalan Tremelimumab

MeSH Conditions

Multiple Myeloma

Other Conditions


Stopping Reasons

FDA placed on partial hold due to additional data

Limitations And Caveats

Early termination due to safety signals in other studies investigating combination regimens comprising similar drugs. Because only 6 subjects were enrolled, no final statistical analysis plan was issued and no formal data analyses were performed.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID